The 14th consecutive presence of Pars Isotope at the Annual European Association of Nuclear Medicine Congress (EANM 2025)
The CEO of Pars Isotope at the closing ceremony of the 25th Iranian Nuclear Medicine Congress: ‘Expanding production of new radiopharmaceuticals is among Pars Isotope’s top priorities.
President Unveils Three New Radiopharmaceuticals by Pars Isotope at 19th National Nuclear Technology Festival
The successful presence of Pars Isotope at the 9th International Congress and the 19th Annual Congress of Clinical Oncology
The presence of Pars Isotope at the 7th Conference on Measurement and Safety of Ionizing and Non-Ionizing Radiation
